Brief: Pharmaust Says Michael Thurn Appointed As CEO Effective 1 September
Aug 28 (Reuters) - Pharmaust PAA.AX :
* MICHAEL THURN APPOINTED AS CEO EFFECTIVE 1 SEPTEMBER
* ROGER ASTON WILL REMAIN CHAIRMAN OF BOARD BUT WILL
TRANSITION
INTO NON-EXECUTIVE ROLE
Source text for Eikon: ID:nASX2m0CCw
Further company coverage: PAA.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Neurizon Therapeutics
See all newsAustralia's Neurizon jumps on potential for neurodegenerative drug approval
Brief: Neurizon Therapeutics' Ongoing Healey ALS Platform Trial Affirmed By FDA
Brief: Neurizon Therapeutics Says Dr Chris Bremer Commences As CEO
Brief: Neurizon Therapeutics Appoints Chris Bremer As Chief Executive Officer
Brief: Neurizon Therapeutics Enters Strategic Research And Development Financing Facility